B6;129P2-Kitd18/Cnrm

Status

Available to order

EMMA IDEM:01541
International strain nameB6;129P2-Kitd18/Cnrm
Alternative nameKit delta ex18
Strain typeInduced Mutant Strains : Chemically-induced
Allele/Transgene symbolKitd18
Gene/Transgene symbolKit

Information from provider

ProviderBoris Greber
Provider affiliationMax Planck Institute for Brain Research, Max Planck Institute for Brain Research
Genetic informationThe mutant ES cell clone was isolated from an archive of ENU-treated cells via an RT genotyping-based screening protocol aiming at the identification of splice mutations. Underlying mutation: the canonical splice donor site (GT) of Kit intron 18 has been changed to AT leading to the skipping of exon 18 at the RNA level.
Phenotypic informationThere are pleiotropic defects associated with mutations in the Kit gene. We have only investigated pigmentation defects. Heterozygous mice of line Kit delta ex18 lack pigmentation at the following zones: parts of the belly, feet, tail tip. Homozygous mice are entirely devoid of pigmentation.
Breeding historyChimeric mice were generated by injecting mutant clone E14.1 ES cells (129P2/OlaHsd) into C57BL/6 blastocysts followed by embryo transfer into pseudopregnant females. Resulting chimeras were mated to C57BL/6 females. Offspring of a heterozygous founder animal were mated to each other resulting in heterozygous and homozygous mutants (current status).
References
  • Mouse splice mutant generation from ENU-treated ES cells--a gene-driven approach.;Greber Boris, Lehrach Hans, Himmelbauer Heinz, ;2005;Genomics;85;557-62; 15820307

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • belly spot / MGI
MGI phenotypes (gene matching)
  • abnormal ear pigmentation / MGI
  • abnormal cochlea morphology / MGI
  • abnormal organ of Corti morphology / MGI
  • organ of Corti degeneration / MGI
  • abnormal stria vascularis morphology / MGI
  • decreased circulating LDL cholesterol level / MGI
  • decreased circulating HDL cholesterol level / MGI
  • decreased hematocrit / MGI
  • abnormal erythropoiesis / MGI
  • macrocytosis / MGI
  • increased mast cell number / MGI
  • decreased bone marrow cell number / MGI
  • decreased mast cell number / MGI
  • altered response to myocardial infarction / MGI
  • head blaze / MGI
  • diluted coat color / MGI
  • irregular coat pigmentation / MGI
  • belly spot / MGI
  • alopecia / MGI
  • abnormal digestive system morphology / MGI
  • abnormal esophagus morphology / MGI
  • abnormal cecum morphology / MGI
  • enlarged spleen / MGI
  • spleen hyperplasia / MGI
  • spleen hypoplasia / MGI
  • decreased thymocyte number / MGI
  • abnormal female reproductive system morphology / MGI
  • abnormal oocyte morphology / MGI
  • abnormal ovary morphology / MGI
  • small ovary / MGI
  • ovary hyperplasia / MGI
  • impaired ovarian folliculogenesis / MGI
  • abnormal ovarian folliculogenesis / MGI
  • abnormal ovarian follicle morphology / MGI
  • constricted vagina orifice / MGI
  • abnormal male reproductive system morphology / MGI
  • small testis / MGI
  • Leydig cell hyperplasia / MGI
  • arrest of spermatogenesis / MGI
  • abnormal spermatogenesis / MGI
  • pigmentation phenotype / MGI
  • hyperpigmentation / MGI
  • absent skin pigmentation / MGI
  • reddish skin / MGI
  • decreased body weight / MGI
  • distended abdomen / MGI
  • abnormal eye pigmentation / MGI
  • anemia / MGI
  • abnormal erythrocyte cell number / MGI
  • abnormal vascular permeability / MGI
  • abnormal digestive system physiology / MGI
  • postnatal growth retardation / MGI
  • increased circulating luteinizing hormone level / MGI
  • arrested B cell differentiation / MGI
  • kidney inflammation / MGI
  • decreased inflammatory response / MGI
  • reduced fertility / MGI
  • reduced male fertility / MGI
  • reduced female fertility / MGI
  • infertility / MGI
  • male infertility / MGI
  • female infertility / MGI
  • decreased litter size / MGI
  • testis hypoplasia / MGI
  • deafness / MGI
  • increased papilloma incidence / MGI
  • ovary cysts / MGI
  • abnormal coat/hair pigmentation / MGI
  • prenatal lethality / MGI
  • perinatal lethality / MGI
  • postnatal lethality / MGI
  • premature death / MGI
  • abnormal skin pigmentation / MGI
  • abnormal muscle physiology / MGI
  • abnormal definitive hematopoiesis / MGI
  • abnormal B cell differentiation / MGI
  • abnormal T cell differentiation / MGI
  • abnormal seminiferous tubule morphology / MGI
  • decreased airway responsiveness / MGI
  • abnormal proerythroblast morphology / MGI
  • abnormal mast cell physiology / MGI
  • abnormal erythrocyte morphology / MGI
  • increased mean corpuscular volume / MGI
  • decreased mean corpuscular volume / MGI
  • high mean erythrocyte cell number / MGI
  • low mean erythrocyte cell number / MGI
  • increased mean platelet volume / MGI
  • decreased basophil cell number / MGI
  • increased hematocrit / MGI
  • hepatic steatosis / MGI
  • belted / MGI
  • asthenozoospermia / MGI
  • abnormal spermatogonia proliferation / MGI
  • oligozoospermia / MGI
  • absent ovarian follicles / MGI
  • abnormal Sertoli cell morphology / MGI
  • microcytic anemia / MGI
  • macrocytic anemia / MGI
  • abnormal cochlear ganglion morphology / MGI
  • cochlear ganglion degeneration / MGI
  • polycythemia / MGI
  • decreased hemoglobin content / MGI
  • decreased erythrocyte cell number / MGI
  • abnormal melanocyte morphology / MGI
  • abnormal otolith morphology / MGI
  • white spotting / MGI
  • head spot / MGI
  • variable body spotting / MGI
  • increased urine protein level / MGI
  • abnormal primordial germ cell migration / MGI
  • no phenotypic analysis / MGI
  • increased myocardial infarction size / MGI
  • decreased vascular permeability / MGI
  • increased erythrocyte cell number / MGI
  • increased erythroid progenitor cell number / MGI
  • enlarged otoliths / MGI
  • abnormal tectorial membrane morphology / MGI
  • reversion by mitotic recombination / MGI
  • intestinal obstruction / MGI
  • increased esophageal papilloma incidence / MGI
  • peptic ulcer / MGI
  • decreased susceptibility to induced arthritis / MGI
  • decreased tumor growth/size / MGI
  • abnormal response/metabolism to endogenous compounds / MGI
  • abnormal male reproductive system physiology / MGI
  • pallor / MGI
  • increased tumor growth/size / MGI
  • belly blaze / MGI
  • decreased fetal size / MGI
  • vestibular hair cell degeneration / MGI
  • cochlear hair cell degeneration / MGI
  • thin stria vascularis / MGI
  • abnormal strial basal cell morphology / MGI
  • abnormal strial marginal cell morphology / MGI
  • abnormal stria vascularis vasculature morphology / MGI
  • abnormal cochlear outer hair cell morphology / MGI
  • absent endocochlear potential / MGI
  • absent oocytes / MGI
  • decreased testis weight / MGI
  • decreased male germ cell number / MGI
  • decreased epididymis weight / MGI
  • increased B cell number / MGI
  • decreased B cell number / MGI
  • increased susceptibility to parasitic infection / MGI
  • abnormal melanosome morphology / MGI
  • azoospermia / MGI
  • absent coat pigmentation / MGI
  • non-pigmented tail tip / MGI
  • decreased circulating cholesterol level / MGI
  • abnormal renal glomerulus morphology / MGI
  • homeostasis/metabolism phenotype / MGI
  • hearing/vestibular/ear phenotype / MGI
  • growth/size/body region phenotype / MGI
  • digestive/alimentary phenotype / MGI
  • immune system phenotype / MGI
  • reproductive system phenotype / MGI
  • hematopoietic system phenotype / MGI
  • abnormal action potential / MGI
  • thrombocytosis / MGI
  • abnormal body temperature / MGI
  • increased mean corpuscular hemoglobin / MGI
  • increased hemoglobin content / MGI
  • decreased susceptibility to type I hypersensitivity reaction / MGI
  • increased bleeding time / MGI
  • increased mean corpuscular hemoglobin concentration / MGI
  • abnormal response to transplant / MGI
  • absent strial intermediate cells / MGI
  • abnormal vestibular saccule morphology / MGI
  • abnormal female germ cell morphology / MGI
  • abnormal male germ cell morphology / MGI
  • decreased Cajal-Retzius cell number / MGI
  • abnormal ventral coat pigmentation / MGI
  • increased megakaryocyte cell number / MGI
  • abnormal primordial germ cell proliferation / MGI
  • abnormal primordial germ cell morphology / MGI
  • slow postnatal weight gain / MGI
  • impaired neutrophil recruitment / MGI
  • abnormal interferon level / MGI
  • abnormal interleukin level / MGI
  • increased mast cell degranulation / MGI
  • decreased mast cell degranulation / MGI
  • decreased survivor rate / MGI
  • abnormal erythroid progenitor cell morphology / MGI
  • abnormal ovarian follicle number / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • decreased physiological sensitivity to xenobiotic / MGI
  • delayed female fertility / MGI
  • meteorism / MGI
  • abnormal primordial ovarian follicle morphology / MGI
  • abnormal foot pigmentation / MGI
  • enlarged cecum / MGI
  • small cecum / MGI
  • distended cecum / MGI
  • distended ileum / MGI
  • distended stomach / MGI
  • increased gastrointestinal stromal tumor incidence / MGI
  • abnormal interstitial cell of Cajal morphology / MGI
  • interstitial cells of Cajal hyperplasia / MGI
  • impaired behavioral response to xenobiotic / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • increased sensitivity to xenobiotic induced morbidity/mortality / MGI
  • abnormal melanoblast morphology / MGI
  • abnormal melanoblast migration / MGI
  • variable depigmentation / MGI
  • increased gastrointestinal tumor incidence / MGI
  • abnormal survival / MGI
  • abnormal myenteric nerve plexus morphology / MGI
  • lethality, incomplete penetrance / MGI
  • lethality at weaning, incomplete penetrance / MGI
  • postnatal lethality, complete penetrance / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • neonatal lethality, complete penetrance / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI
  • perinatal lethality, incomplete penetrance / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality before implantation, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI
  • preweaning lethality, incomplete penetrance / MGI
  • increased erythroblast number / MGI
  • increased erythrocyte protoporphyrin level / MGI
  • decreased tail pigmentation / MGI
  • decreased ear pigmentation / MGI
  • glomerular crescent / MGI
  • increased or absent threshold for auditory brainstem response / MGI
  • abnormal circulating histamine level / MGI

Literature references

  • Mouse splice mutant generation from ENU-treated ES cells--a gene-driven approach.;Greber Boris, Lehrach Hans, Himmelbauer Heinz, ;2005;Genomics;85;557-62; 15820307

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).